Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
4.78
Dollar change
-0.20
Percentage change
-4.02
%
Index- P/E- EPS (ttm)-1.29 Insider Own19.75% Shs Outstand34.34M Perf Week-9.13%
Market Cap164.15M Forward P/E- EPS next Y-0.96 Insider Trans0.30% Shs Float27.56M Perf Month-4.40%
Income-27.32M PEG- EPS next Q-0.24 Inst Own48.61% Short Float3.45% Perf Quarter4.82%
Sales0.00M P/S- EPS this Y27.71% Inst Trans1.44% Short Ratio8.57 Perf Half Y50.31%
Book/sh1.44 P/B3.31 EPS next Y11.77% ROA-60.15% Short Interest0.95M Perf Year-17.73%
Cash/sh1.93 P/C2.47 EPS next 5Y15.00% ROE-109.49% 52W Range3.03 - 6.18 Perf YTD16.02%
Dividend Est.- P/FCF- EPS past 5Y53.91% ROI-55.23% 52W High-22.65% Beta1.55
Dividend TTM- Quick Ratio3.29 Sales past 5Y0.00% Gross Margin- 52W Low57.76% ATR (14)0.24
Dividend Ex-Date- Current Ratio3.29 EPS Y/Y TTM65.82% Oper. Margin0.00% RSI (14)38.58 Volatility4.61% 4.73%
Employees22 Debt/Eq0.35 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price17.25
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q48.33% Payout- Rel Volume1.55 Prev Close4.98
Sales Surprise- EPS Surprise-7.57% Sales Q/Q- EarningsMay 09 AMC Avg Volume110.78K Price4.78
SMA20-8.87% SMA50-1.65% SMA2005.17% Trades Volume171,219 Change-4.02%
Date Action Analyst Rating Change Price Target Change
May-10-23Reiterated Maxim Group Buy $8 → $20
Jun-23-21Initiated Oppenheimer Outperform $23
May-29-24 08:00AM
May-17-24 08:00AM
May-13-24 08:55AM
May-10-24 03:47PM
12:41PM
04:01PM Loading…
May-09-24 04:01PM
May-06-24 11:16AM
Apr-29-24 09:00AM
Apr-25-24 08:00AM
Apr-11-24 08:00AM
Apr-01-24 03:30PM
Mar-29-24 06:24AM
Mar-28-24 08:53PM
05:32PM
04:01PM
08:00AM Loading…
Mar-20-24 08:00AM
Mar-14-24 08:00AM
Mar-08-24 08:35AM
Mar-06-24 08:00AM
Mar-05-24 08:35AM
Feb-29-24 08:01AM
08:00AM
Dec-15-23 08:35AM
Dec-13-23 08:00AM
Dec-12-23 01:02PM
09:10AM
Dec-11-23 04:30PM
Nov-11-23 10:36AM
Nov-10-23 10:01AM
Nov-09-23 04:00PM
08:00AM Loading…
Oct-26-23 08:00AM
Oct-03-23 08:00AM
Sep-11-23 08:00AM
Sep-07-23 08:00AM
Aug-16-23 10:30AM
Aug-15-23 10:25PM
Aug-14-23 04:00PM
Aug-01-23 08:00AM
Jul-18-23 08:00AM
Jul-11-23 11:23AM
May-25-23 09:00AM
07:16AM
May-24-23 06:10AM
May-23-23 02:46PM
06:00AM
May-17-23 08:00AM
May-10-23 09:08AM
05:57AM
May-09-23 04:05PM
Apr-26-23 08:00AM
Apr-24-23 05:27AM
Apr-20-23 02:22PM
08:00AM
Apr-14-23 08:00AM
Mar-30-23 08:00AM
Mar-29-23 08:00AM
Mar-20-23 10:46PM
05:27AM
Mar-17-23 08:00AM
05:48AM
Mar-16-23 04:05PM
Mar-08-23 08:00AM
Mar-03-23 08:00AM
Mar-02-23 08:00AM
Feb-15-23 05:42AM
Feb-07-23 08:00AM
Feb-02-23 08:00AM
Jan-27-23 04:30PM
Jan-09-23 08:00AM
Dec-29-22 06:02AM
Dec-21-22 08:00AM
Nov-21-22 06:01AM
Nov-15-22 08:00AM
Nov-14-22 04:05PM
Nov-08-22 08:00AM
Oct-31-22 08:00AM
Sep-27-22 08:00AM
Sep-07-22 08:00AM
Aug-15-22 06:16AM
Aug-11-22 04:05PM
Jul-28-22 08:00AM
Jul-01-22 04:05PM
Jun-29-22 08:00AM
Jun-21-22 08:00AM
Jun-01-22 08:00AM
May-26-22 08:00AM
May-16-22 01:20PM
May-13-22 08:00AM
06:30AM
May-12-22 04:00PM
May-05-22 02:59PM
Apr-28-22 05:22AM
Apr-27-22 09:40AM
08:00AM
Apr-21-22 08:00AM
Mar-15-22 08:00AM
Mar-14-22 08:00AM
Mar-11-22 08:06AM
08:00AM
Mar-10-22 08:00AM
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wan JerryPrincipal Accounting OfficerApr 19 '24Option Exercise0.005,625012,057Apr 23 04:39 PM
JACOBS CINDYPresident & CMOApr 19 '24Option Exercise0.0016,250034,511Apr 23 04:35 PM
Stewart Richard AlistairExecutive ChairmanApr 19 '24Option Exercise0.0022,500061,001Apr 23 04:31 PM
Bencich JohnCEOApr 19 '24Option Exercise0.0025,0000101,724Apr 23 04:26 PM
Stewart Richard AlistairExecutive ChairmanMar 04 '24Buy4.5810,00045,85038,501Mar 06 04:49 PM
Bencich JohnCEOMar 04 '24Buy4.5810,00045,85076,724Mar 06 04:43 PM